Axios Visuals It's not food, it's not chewing tobacco and it's not gum — though it might look like it when you see it — but it is becoming America's new addictive obsession. Why it matters: Sales of ...

Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's authorization noted the pouches ...

CPEAR’s poll is a thinly veiled attempt to persuade policymakers to take a broadly popular issue in a less popular direction.

S&P 500 surges in H1 2025; explore AI leaders & ETFs for H2. Click to learn more about stocks to avoid and tips to navigate ...

R.J. Reynolds Vapor Co.’s Vuse remains the top-selling e-cigarette brand with a 34.9% market share, while Geek Bar Pule by ...

PM, MO and TPB are riding a wave of RRP innovation and pricing power as the tobacco industry pivots toward smoke-free growth.

A small firm near Chicago is under scrutiny for importing millions of unauthorized Chinese vapes into the U.S., becoming a key player in the illegal e-cigarette supply chain. Despite FDA warnings ...

Recent restructuring efforts at the Food and Drug Administration may have been well-intentioned, but they risk undermining the very innovation and domestic capacity the president seeks to promote.

"The FDA’s order sounded the death knell for a significant portion of the e-cigarette market, and (Reynolds) Vapor sought to challenge it," Justice Amy Coney Barrett wrote.

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

House FY26 bill allocates $6.7B to Food and Drug Administration, $22B to USDA; restricts sodium, Listeria rules, clarifies hemp scope, and delays “healthy” rule enfo ...

The Food and Drug Administration has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.